C-JUN anticorps (AA 221-250)
-
- Antigène Voir toutes C-JUN (JUN) Anticorps
- C-JUN (JUN) (Jun Proto-Oncogene (JUN))
-
Épitope
- AA 221-250
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp C-JUN est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Homologie
- B, C, M, Pig, Rat
- Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogène
- This JUN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 221-250 amino acids from human JUN.
- Clone
- RB11143
- Isotype
- Ig Fraction
- Top Product
- Discover our top product JUN Anticorps primaire
-
-
- Indications d'application
- WB: 1:1000. IHC-P: 1:10~50
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Date de péremption
- 6 months
-
-
Is B-Raf a good therapeutic target for melanoma and other malignancies?" dans: Cancer research, Vol. 68, Issue 1, pp. 5-8, (2008) (PubMed).
: "miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism." dans: Journal of molecular biology, Vol. 378, Issue 3, pp. 492-504, (2008) (PubMed).
: "Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction." dans: The Journal of cell biology, Vol. 180, Issue 6, pp. 1087-100, (2008) (PubMed).
: "
-
Is B-Raf a good therapeutic target for melanoma and other malignancies?" dans: Cancer research, Vol. 68, Issue 1, pp. 5-8, (2008) (PubMed).
-
- Antigène
- C-JUN (JUN) (Jun Proto-Oncogene (JUN))
- Autre désignation
- JUN (JUN Produits)
- Synonymes
- anticorps AP-1, anticorps AP1, anticorps c-Jun, anticorps fj36h07, anticorps wu:fj36h07, anticorps zgc:65863, anticorps Junc, anticorps c-jun, anticorps CG2275, anticorps D-Jun, anticorps D-jun, anticorps D-jun/Jra, anticorps DJUN, anticorps DJun, anticorps Djun, anticorps Dmel\\CG2275, anticorps JRA, anticorps JUN, anticorps Jun, anticorps V, anticorps cJun, anticorps d-JRA, anticorps d-Jun, anticorps d-jun, anticorps dAP-1, anticorps dJRA, anticorps dJUN, anticorps dJra, anticorps dJun, anticorps djun, anticorps dm-Jun, anticorps jra, anticorps jun, anticorps l(2)46Ef, anticorps l(2)IA109, anticorps l(2R)IA109, anticorps Jun proto-oncogene, AP-1 transcription factor subunit, anticorps jun proto-oncogene S homeolog, anticorps jun proto-oncogene, anticorps Jun-related antigen, anticorps jun proto-oncogene L homeolog, anticorps JUN, anticorps Jun, anticorps jun.S, anticorps jun, anticorps Jra, anticorps jun.L
- Sujet
- JUN interacts directly with specific target DNA sequences to regulate gene expression.
- Poids moléculaire
- 35676
- NCBI Accession
- NP_002219
- UniProt
- P05412
- Pathways
- Signalisation MAPK, Signalisation RTK, Signalisation WNT, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Myometrial Relaxation and Contraction, Skeletal Muscle Fiber Development, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Autophagy, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling, S100 Proteins
-